Top compounds associated with response to LMLN


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.064 0.09
mRNA etoposide CTRPv2 pan-cancer AAC -0.051 0.09
mRNA WZ-1-84 GDSC1000 pan-cancer AAC 0.093 0.1
mRNA NPC-26 CTRPv2 pan-cancer AAC 0.066 0.1
mRNA BRD-K58730230 CTRPv2 pan-cancer AAC -0.13 0.1
mRNA SRT-1720 CTRPv2 pan-cancer AAC -0.063 0.1
mRNA QL-XII-47 GDSC1000 pan-cancer AAC 0.055 0.1
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.059 0.1
mRNA thalidomide CTRPv2 pan-cancer AAC 0.092 0.1
mRNA temsirolimus CTRPv2 pan-cancer AAC 0.081 0.1
Download CSV